Most stem cell research targeted at the heart uses adult stem cells.
The FDA regulates adult stem cell techniques that are allowed to go into clinical trials.
Unlike organ transplants, adult stem cells generally can be given to any patient.
Therapies be available in a little over four years, although some say five to 10.
